Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis

Fig. 3

Time profile of daily diary scores among csDMARD/MTX-IR patients who were retreated following interruptionsa. Data presented are combined from RA-BEAM and RA-BUILD for duration of morning joint stiffness (a) morning joint stiffness severity (b), worst joint pain (c), and worst tiredness (d); electronic diary data were gathered daily from week 0 to 12. aExcludes interruptions without at least 3 diary entries during interruption. bAverage of values obtained within the first 3 days following randomization. cAverage of up to 3 most recent values obtained in the 7 days prior to interruption. dAverage of 3 most recent values in the last 7 days of the interruption. eAverage of last 3 available values obtained following interruption and prior to any subsequent interruption or week 12 study visit. N, number of interruptions with complete time profile; NRS, numeric rating scale

Back to article page